Abivax S.A. (ABVX)

R&D Expenses

€180.68M

TTM · Period ending: · EUR

ABVX logo

ABVX R&D Expenses

Latest reported€180.68M EUR
ABVX R&D Expenses · EUR (€0.00 → €180.68M)
High-resolution chart · PNG

ABVX r&d expenses history

Annual fiscal periods · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

Abivax S.A. R&D Expenses — Annual fiscal periods (EUR)
Period endingR&D Expenses (EUR)
177,761,000
146,532,000
103,176,000
48,295,000
47,781,000
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.